Nifurpipone acetate | CAS# 51799-29-2 (acetate)

MedKoo Cat#: 414382 | Name: Nifurpipone acetate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nifurpipone acetate is a biochemical found in urine.

Chemical Structure

Nifurpipone acetate

CAS#51799-29-2 (acetate)

Theoretical Analysis

MedKoo Cat#: 414382

Name: Nifurpipone acetate

CAS#: 51799-29-2 (acetate)

Chemical Formula: C14H21N5O6

Exact Mass: 355.1492

Molecular Weight: 355.35

Elemental Analysis: C, 47.32; H, 5.96; N, 19.71; O, 27.01

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

56217-89-1 (HCl) 51799-29-2 (acetate) 24632-48-2 (2HCl) 24632-47-1 (free base)

Synonym

Nifurpipone acetate

IUPAC/Chemical Name

1-Piperazineacetic acid, 4-methyl-, ((5-nitro-2-furanyl)methylene)hydrazide, acetate

InChi Key

FUFPEEYFYAAKCK-FNXZNAJJSA-N

InChi Code

InChI=1S/C12H17N5O4.C2H4O2/c1-15-4-6-16(7-5-15)9-11(18)14-13-8-10-2-3-12(21-10)17(19)20;1-2(3)4/h2-3,8H,4-7,9H2,1H3,(H,14,18);1H3,(H,3,4)/b13-8+;

SMILES Code

O=C(N/N=C/C1=CC=C([N+]([O-])=O)O1)CN2CCN(C)CC2.CC(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 355.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Veronese M, Salvaterra M, Barzaghi D, Setnikar I. Effects of different drugs on the urinary excretion of nifurpipone (NP) and of nitrofurantoin (NTF) in the rat. Arzneimittelforschung. 1975 Sep;25(9):1417-20. PubMed PMID: 1242665. 2: Setnikar I, Magistretti MJ. Toxicological studies on nifurpipone. Boll Chim Farm. 1975 Feb;114(2):73-84. PubMed PMID: 1203104. 3: Barzaghi D, Benvenuti C, Pariali A, Veronese M. [Various methods for determination of nifurpipone in the human urine]. Farmaco Prat. 1976 Jul;31(7):377-82. Italian. PubMed PMID: 821781. 4: Laudi M, Ferrando V, Fontana G, Sesia G. [Nifurpipone in inflammatory diseases of the urinary tract]. Minerva Urol. 1973 May-Jun;25(3):149-57. Italian. PubMed PMID: 4583091. 5: Fontani F, Setnikar I. [Example of chemico-physical characterization of new drug (nifurpipone)]. Farmaco Prat. 1973 Oct;28(10):547-58. Italian. PubMed PMID: 4769274. 6: Veronese M, Salvaterra M, Barzaghi D, Setnikar I. Urinary excretion in the rat of nifurpipone (NP) and of nitrofurantoin (NTF) administered by different routes. Arzneimittelforschung. 1974 Jan;24(1):39-43. PubMed PMID: 4206385. 7: Watts ME. Radiosensitization of hypoxic cells by a nitrofuran; dose-modifying and shoulder effects. Int J Radiat Biol Relat Stud Phys Chem Med. 1977 Mar;31(3):237-50. PubMed PMID: 323170. 8: Fontani F, Massarani E, Nardi D, Tajana A. Determination of nifurpipone in urine. J Pharm Sci. 1972 Sep;61(9):1502-3. PubMed PMID: 5068967. 9: Barzaghi D, Benvenuti C, Buffa E, Marozzi E. [Urinary elimination of 4 diverse oral formulations of nifurpipone]. Farmaco Prat. 1977 Feb;32(2):92-8. Italian. PubMed PMID: 849778. 10: Veronese M, Setnikar I. [Nifurpipone disks for antibiograms]. Boll Chim Farm. 1975 Oct;114(10):577-81. Italian. PubMed PMID: 1220715. 11: Bompani R, Pesci M, Petronio G. [Nifurpipone in the chemotherapy of bacterial inflammation of the urinary ways in geriatrics]. Minerva Urol. 1975 Jan-Feb;27(1):12-23. Italian. PubMed PMID: 1196269. 12: Massarani E, Nardi D, Degen L, Setnikar I. Nifurpipone, a new nitrofuran with a large antimicrobial spectrum. Experientia. 1971 Oct 15;27(10):1243-4. PubMed PMID: 5001825. 13: Fisher GJ, Watts ME, Patel KB, Adams GE. Sensitization of ultraviolet radiation damage in bacteria and mammalian cells. Br J Cancer Suppl. 1978 Jun;3:111-4. PubMed PMID: 354675; PubMed Central PMCID: PMC2149378. 14: Sheldon PW, Hill SA. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br J Cancer. 1977 Jun;35(6):795-808. PubMed PMID: 871367; PubMed Central PMCID: PMC2025527. 15: Michaels HB. Oxygen depletion in irradiated aqueous solutions containing electron affinic hypoxic cell radiosensitizers. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1055-8. PubMed PMID: 3744926. 16: Denekamp J, Michael BD, Harris SR. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat Res. 1974 Oct;60(1):119-32. PubMed PMID: 10881705.